Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infe
about
Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumoniaValue of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort studyUsefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic reviewBiomarkers in sepsisBiomarkers of sepsissuPAR as a prognostic biomarker in sepsisThe electrocardiogram for sepsis: how close are we?Clinical value of plasma soluble urokinase-type plasminogen activator receptor levels in term neonates with infection or sepsis: a prospective study.Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study.Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis.Changes in mipomersen dosing regimen provide similar exposure with improved tolerability in randomized placebo-controlled study of healthy volunteersNew approaches to sepsis: molecular diagnostics and biomarkers.Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis/septic shock in the emergency department.Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke.Diagnostic value of sTREM-1 in bronchoalveolar lavage fluid in ICU patients with bacterial lung infections: a bivariate meta-analysisClinical evaluation of multiple inflammation biomarkers for diagnosis and prognosis for patients with systemic inflammatory response syndromeUtility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patientsBiomarkers as outcome predictors in subarachnoid hemorrhage--a systematic reviewSoluble urokinase-type plasminogen activator receptor levels in patients with schizophreniaPredictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational studyCirculating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patientsTREM-1 signaling promotes host defense during the early stage of infection with highly pathogenic Streptococcus suis.The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis.The Clinical Challenge of Sepsis Identification and MonitoringSerum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis.Immature platelet fraction in septic patients: clinical relevance of immature platelet fraction is limited to the sensitive and accurate discrimination of septic patients from non-septic patients, not to the discrimination of sepsis severityBiomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study.Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassaysUseulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine.C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency departmentRole of biomarkers in sepsis care.Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis.Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.Biomarkers for sepsis: a review with special attention to India.Macrophage migration inhibitory factor (MIF): a promising biomarker.Biomarkers for pediatric sepsis and septic shock.Clinical application of sepsis biomarkers.Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis.Diagnostic and prognostic markers in sepsis.Sepsis biomarkers: an omics perspective.
P2860
Q21194921-AC7938B6-A557-4A59-8A14-385D424D08B4Q21261826-9012D79B-BB23-4303-BF14-6603EE4E9C15Q24614787-3E74665A-25E3-479C-898E-ECF5146D7E8CQ26821873-5F51405D-10B2-476E-99AA-B1E5730D992DQ26822575-ABE3F2CB-32ED-4354-A83C-7F04BA58A9C1Q26858996-E92081B3-9E8B-43DA-A266-9F57564F9F2DQ28217952-16ECDC63-55B4-4E0E-A89C-6D1166D65C36Q33634943-9E7301D5-EB9B-43E1-A0F5-38415F8AB16EQ33831130-4F9207C6-3129-4F5C-BAC5-D115438F059AQ34062904-D905B7F4-1126-4FB9-AFE8-366A65D25665Q34297049-74A1F3CA-93D5-4AD2-B1FD-B08A594C4374Q34303687-9B1E606E-9B78-416D-A441-9D7850452E82Q34400758-5B7AA92D-5800-485B-A7E7-84643582D256Q34464946-5AA9D54B-3463-4600-8BDF-DFEABC3D8C19Q34755994-72405F8F-C410-4B28-8E36-73602D7ED10CQ35036096-A29FD5A9-1447-4AF2-8C35-D73CBCDFA1BCQ35070651-647A363A-D9AF-4E5D-9542-F4FFB4FB45DFQ35136554-6F4F6C19-378C-4A3F-BD05-124D2144A390Q35369617-DA3A718A-72DB-46E2-8E2F-79B83BA14311Q35561237-33799A31-CA5F-4A13-BC37-76C1947EA100Q35567020-A6C835EB-C5EC-4A61-9047-D314363647E7Q35833815-86ED2202-A21E-44CC-93BB-87265FE062C7Q35896513-02B6AF4D-8C7C-468D-AC8A-E8546BC42B0BQ36020055-D1ED16FF-7535-41F8-88C2-73693D738925Q36227804-9FFA9D7C-6DE9-43EE-BDF5-F4916FD037DDQ36419666-6BAAECB6-A28E-4051-8A0A-EDC0AA995BA9Q36795684-E76D0FA7-A6F6-4655-8DBE-8D878F89EDDDQ36955225-95619422-CC80-4853-9830-1FFD6E2BCE9CQ37207285-66141661-6118-4DA4-94F5-BF89C02853A7Q37210120-ED514F12-8A26-4D46-94AD-A0639F7F0D38Q37249625-5030FB39-D843-49DE-A129-D48C12A4D3D9Q37496755-B01BB50C-18A7-498E-B460-8BC2AC9B6E82Q37655890-FEDB2C18-12A2-4C29-8B03-62E16254CD7CQ37688126-AF65EDAD-4557-4A4C-8538-A8776CD911C1Q37762450-EACE3CB8-839F-4748-A252-DA1121772D0DQ37822454-0E95C228-F830-40A4-AAF7-A16232C09E43Q38056387-88CED273-B786-47C2-AD9B-1AB55611E2CFQ38063551-EE8B4215-300B-4093-82FF-F1D108805615Q38086336-79A2E07D-715A-4553-A453-03D6ACC9E446Q38183729-B6BA73C8-EE7F-4C4A-A3CD-3F667422BFAE
P2860
Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infe
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Use of plasma C-reactive prote ...... n combination to diagnose infe
@ast
Use of plasma C-reactive prote ...... n combination to diagnose infe
@en
type
label
Use of plasma C-reactive prote ...... n combination to diagnose infe
@ast
Use of plasma C-reactive prote ...... n combination to diagnose infe
@en
prefLabel
Use of plasma C-reactive prote ...... n combination to diagnose infe
@ast
Use of plasma C-reactive prote ...... n combination to diagnose infe
@en
P2093
P2860
P356
P1433
P1476
Use of plasma C-reactive prote ...... n combination to diagnose infe
@en
P2093
Gitte Kronborg
Janne Petersen
Klaus Larsen
Kristian Kofoed
Michael Tvede
P2860
P2888
P356
10.1186/CC5723
P577
2007-01-01T00:00:00Z
P5875
P6179
1001948339